跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HERCEPTIN SC - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
HERCEPTIN SC
Authorized
STANDARD
HERCEPTIN SC
Hoffmann-La Roche Limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f1b105304821ba57
Company
Hoffmann-La Roche Limited
Type
Standard
Approval Details
Approval Id
f1b105304821ba57
Drug Approval Canada Name
HERCEPTIN SC
Product Name
HERCEPTIN SC
Status
Marketed
Status Date
2018-10-12
Original Market Date
2018-10-12
Din
02480697
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription , Schedule D
Ahfs
10:00.00
Atc Original
L01FD01 TRASTUZUMAB
Atc Name
l 01 fd 01
Aig Number
0154252003
Company Name
Hoffmann-La Roche Limited
Company Address
7070 Mississauga Road, Mississauga, Ontario, Canada, L5N 5M8
Active Ingredients
TRASTUZUMAB
600 MG / 5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f1b105304821ba57
Type
Standard
Back to Health Canada Approvals